Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

prostate cancer

  • Open Access
    The immune landscape of systemic inflammation in prostate cancer
    Liang Zhang, Jiangling Fu, Xiaoliang Liu, Shangzhi Feng and Yuanjing Leng
    Cancer Biology & Medicine August 2025, 22 (8) 881-902; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0149
  • Open Access
    Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents
    Jinge Zhao, Junru Chen, Guangxi Sun, Pengfei Shen and Hao Zeng
    Cancer Biology & Medicine November 2024, 21 (11) 1012-1032; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0139
  • You have access
    Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer
    Nanhui Chen, Zengjun Wang, Ming Chen, Qi Ma, Yi He, Yujie Wang, Xin Li, Mingxing Qiu, Lei Shi, Shaoxing Zhu, Qun Xie, Xiuheng Liu, Benkang Shi, Guowen Lin, Weizhong Yang, Yongbin Liao, Haibin Zhang, Shusheng Wang, Jiexian Li, Shaogang Wang, Lijun Dong, Hui Chen, Jiaju Lu, Yongyi Cheng, Xiaoping Zhang, Lulin Ma, Liqun Zhou, He Wang, Shen Li and Dingwei Ye
    Cancer Biology & Medicine December 2023, 20 (12) 1047-1059; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0335
  • You have access
    Therapeutic implications of cancer stem cells in prostate cancer
    Pinaki Banerjee, Prachi Kapse, Shehnaz Siddique, Moumita Kundu, Jasoda Choudhari, Varshasnata Mohanty, Diksha Malhotra, Suresh W. Gosavi, Rajesh N. Gacche and Gopal C. Kundu
    Cancer Biology & Medicine June 2023, 20 (6) 401-420; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0714
  • You have access
    Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
    Huan Xu, Junyi Chen, Zhi Cao, Xi Chen, Caihong Huang, Jin Ji, Yalong Xu, Junfeng Jiang, Yue Wang, Guowang Xu, Lina Zhou, Jingyi He, Xuedong Wei, Jason Boyang Wu, Zhong Wang, Shancheng Ren and Fubo Wang
    Cancer Biology & Medicine September 2022, 19 (9) 1315-1333; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0638
  • You have access
    Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
    Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
    Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550
  • You have access
    IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
    Tingting Feng, Jing Wang, Kai Cheng, Qiqi Lu, Ru Zhao, Shiguan Wang, Qingyun Zhang, Luna Ge, Jihong Pan, Guanhua Song and Lin Wang
    Cancer Biology & Medicine July 2022, 19 (7) 1008-1028; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0583
  • You have access
    BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
    Laura Cortesi, Federica Domati, Annalisa Guida, Isabella Marchi, Angela Toss, Elena Barbieri, Luigi Marcheselli, Marta Venturelli, Simonetta Piana, Claudia Cirilli and Massimo Federico
    Cancer Biology & Medicine May 2021, 18 (2) 470-476; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0481
  • You have access
    Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
    Andreas Marx, Lena Koopmann, Doris Höflmayer, Franziska Büscheck, Claudia Hube-Magg, Stefan Steurer, Till Eichenauer, Till S. Clauditz, Waldemar Wilczak, Ronald Simon, Guido Sauter, Jakob R. Izbicki, Hartwig Huland, Hans Heinzer, Markus Graefen, Alexander Haese, Thorsten Schlomm, Christian Bernreuther, Patrick Lebok and Sarah Bonk
    Cancer Biology & Medicine February 2021, 18 (1) 245-255; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0324
  • You have access
    Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
    Andreas M. Luebke, Ali Attarchi-Tehrani, Jan Meiners, Claudia Hube-Magg, Dagmar S. Lang, Martina Kluth, Maria Christina Tsourlakis, Sarah Minner, Ronald Simon, Guido Sauter, Franziska Büscheck, Frank Jacobsen, Andrea Hinsch, Stefan Steurer, Thorsten Schlomm, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Till S. Clauditz, Eike Burandt, Waldemar Wilczak and Doris Höflmayer
    Cancer Biology & Medicine May 2019, 16 (2) 319-330; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0384

Pages

  • Next
  • 1
  • 2
  • 3

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire